Effects of cenobamate on cognitive performance of epilepsy patients.

Author: AltenmüllerDirk-Matthias, Castillo-RodriguezMaria, HeersMarcel, HirschMartin, KravalisKristina, Martínez-LizanaEva, MetternichBirgitta, PapadopoulouGeorgia, SchuetzElisa, Schulze-BonhageAndreas, WagnerKathrin

Paper Details 
Original Abstract of the Article :
Cenobamate (CNB) is a new antiseizure medication (ASM) for the treatment of focal epilepsy in adults. While efficacy of CNB was confirmed in controlled clinical trials, its effects on cognition are unclear. Cognitive adverse effects of ASM affect quality of life and retention rate. Therefore, we inv...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.seizure.2022.10.004

データ提供:米国国立医学図書館(NLM)

Cenobamate: A New Antiseizure Medication and its Impact on Cognition

Cenobamate (CNB) is a newly introduced antiseizure medication (ASM) for treating focal epilepsy in adults. This research explores the potential impact of CNB on cognitive performance in epilepsy patients. The authors investigated whether adjunctive treatment with CNB is associated with changes in cognitive performance. The study, while acknowledging the need for further research, suggests that the cognitive effects of CNB require careful consideration. The authors emphasize that cognitive adverse effects of ASMs can significantly impact quality of life and treatment adherence.

Cenobamate: Navigating the Balance Between Seizure Control and Cognitive Function

This study highlights the importance of carefully evaluating the cognitive impact of new antiseizure medications. The authors underscore the delicate balance between achieving effective seizure control and maintaining optimal cognitive function. Further research is needed to fully understand the long-term cognitive effects of CNB and to determine effective strategies for managing any potential cognitive side effects.

Open Communication and Monitoring for Epilepsy Patients

For individuals with epilepsy, open communication with their healthcare providers is crucial. If you are taking an ASM, discussing any concerns about cognitive function is essential. Regular cognitive assessments and monitoring can help identify any potential changes and guide appropriate management strategies.

Dr. Camel's Conclusion

Just as a camel navigates the ever-shifting desert landscape, epilepsy patients and their healthcare providers must navigate the complexities of antiseizure medication. This research emphasizes the importance of understanding the cognitive effects of new medications like CNB. It’s a reminder that even seemingly successful treatments can have unintended consequences, highlighting the need for ongoing communication and careful monitoring.

Date :
  1. Date Completed 2022-11-07
  2. Date Revised 2022-11-07
Further Info :

Pubmed ID

36240699

DOI: Digital Object Identifier

10.1016/j.seizure.2022.10.004

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.